This study examined empirically-derived symptom cluster proliles among patients who present with insomnia using clinical data and polysomnography (PSG).
INTRODUCTION
Insomnia is the experience of the difficulty falling asleep, difficulty staying asleep, or early morning awakenings. About one-third to one-half of adults complains of these symptoms. 1 Frequently, other complaints, such as sleepiness, fatigue, and hyperarousal, will occur with nocturnal sleep disturbance. An insomnia disorder is defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 2 as the combination of the nocturnal sleep disturbance with one of these waking complaints at least 3 nights a week for at least 3 months. About 8-10% of the adult population meets these criteria. 3, 4 Insomnia disorder is a heterogeneous condition. 5 This can pose a challenge for optimal patient care, because a 'one size fits all' approach does not provide treatment that is tailored to the patient's unique combination of symptoms. The field of oncology has made great strides towards personalised/precision medicine 6 by acknowledging the heterogeneity within the disease and matching treatment based on the individual's symptom/genetic profiles. Many other areas have followed suit, and we believe that there is room for the same type of personalised medicine in insomnia and that this could greatly improve patient care. A management approach to insomnia disorder that is not confined to diagnostic boundaries and instead considers symptom cluster profiles, might offer a more targeted management by treating the most relevant symptoms. This would translate to assessment and treatment decisions informed by a profile based on the level of severity of each symptom.
This hypothesis is based partly on results from our previous mixed-methods study, 7 which revealed that patients with multiple sleep symptoms tend to understand the symptoms and consequences better than diagnostic categories of sleep disorders. Yet, we as clinicians make decisions largely based on diagnostic categories. Empirically deriving symptom clusters for those who present with insomnia complaints might yield a model for a patient-centred approach. There have been previous attempts to identify nighttime-and daytime symptom cluster profiles in patients with insomnia disorder using data-driven approaches. [8] [9] [10] [11] [12] [13] Similar attempts have been published characterising the heterogeneity of obstructive sleep apnoea. 14, 15 However, most of these studies used cluster analysis to characterise this heterogeneity . In contrast, mixture models, such as latent class or profile analysis (LPA), have certain advantages over cluster analysis as described further in the statistical analysis section.
In general, the primary aim of LPA is to classify individuals into symptom profiles reflecting symptom clusters that consist of homogeneous individuals with regards to continuous observed variables being studied. 18 While ensuring homogeneity within a symptom profile, the different profiles are distinct from each other and are viewed as representing the unobserved heterogeneity across individuals. Therefore, this personcentered analytic technique uses actual empirical data, and not arbitrary dichotomization (such as diagnostic categories), to create quantitatively and qualitatively distinct profiles of individuals based on their dimensional presentation of day-and night-time symptoms of insomnia. Another strength of the analyses is the ability to examine covariates of symptom cluster membership. These may be tested in association with distinct outcome variables, such as treatment response, relapse risk or obstructive sleep apnea (OSA) risk, in future reports.
To our knowledge, only two studies have used mixture models, such as latent profile or class analysis, to identify symptom cluster profiles within insomnia. 16, 17 Those studies, however, did not explore symptom profiles among patients who met criteria for an insomnia disorder. 16, 17 The purpose of this study was to examine whether distinct symptom profiles could be identified across a heterogeneous sample of insomnia patients who are representative of those presenting to a sleep clinic, including those with comorbidities such as Periodic Limb Movement Disorder (PLMD) or OSA. We hypothesised that distinct symptom cluster profiles would emerge. We believe that empirically derived symptom profiles can provide an impetus for a dimensional profile of sleep health, 19 which might be useful for reducing the gap between patient understanding and clinical decision making based on categories.
METHODS

Study Sample
Baseline assessments from two independent projects were used for this analysis.
Individuals underwent a structured interview for sleep disorders 20 and had to meet quantitative criteria for insomnia 21 as determined by a 7-day sleep diary. Eligible participants had to be psychologically and medically stable, as evaluated by a structured interview for clinical disorders (SCID 22 ) and medical exam by a physician (study 2 only) respectively. Lastly, individuals who were not fluent in English were excluded. Individuals who were taking sedative-hypnotic medications were only eligible if they stopped the medication under supervision of their prescribing physician.
There were minor differences in the inclusion criteria for both studies: study 1 targeted individuals over 21 years of age with psychophysiological insomnia 23 , and study 2 targeted individuals over 18 years of age with insomnia disorder and comorbid OSA 24 . For study 1, insomnia had to be present for at least 6 months to meet criteria for chronicity, 25 whereas for study 2 insomnia had to be present for at least 3 months (ICSD-3 26 and DSM-5 criteria 2 ). For study 2, unless agreeing not to drive, individuals who were excessively sleepy were also excluded. Excessive sleepiness was defined by scores on the Epworth Sleepiness Scale 27 score >16 or a score of 3 (high chance) on the ESS question about risk of dozing "In a car, while stopped for a few minutes in traffic" or a report of falling asleep at the wheel, an MVA, or near-miss accident due to sleepiness in the past 24 months, which in the judgment of the study physician was not attributable to acute sleep loss. All participants also had to be naïve to CPAP and CBT-I.
By merging data from these two studies collected at the last step of the screening process (in -lab polysomnography, see below) we were able to capitalise on the homogeneity with regards to inclusion criteria (i.e., both studies included individuals with insomnia disorder) while retaining some heterogeneity with regards to exclusion criteria (i.e., in this analysis we included those who were excluded in both studies i.e., individuals with comorbid OSA [in study 1] and comorbid periodic limb movement [study 1 and 2]).
Procedures
The standard baseline assessment for both studies was designed to mimic common clinic procedures for new patients' evaluations at a sleep clinic. The baseline assessment consisted of a brief phone screen, an in-person interview, and an in-lab polysomnograph (PSG). All individuals provided written informed consent. The institutional review board at Rush University Medical Center approved both studies. Data from participants who had successfully completed the baseline assessment were merged into one dataset.
Measures
At baseline, individuals completed a range of self-report questionnaires, a 7-day sleep diary, and a screening PSG.
Insomnia Severity Index (ISI). 28 The ISI is a brief 7-item scale assessing nocturnal and daytime symptoms of insomnia, which has been used as both a screening and outcome measure in treatment research. Total scores range from 0-28, with higher scores indicative of increase insomnia severity. The ISI has adequate internal consistency with evidence supporting concurrent, predictive, and content validity. 29, 30 Glasgow Sleep Effort Scale (GSES). 31 The GSES measures sleep-related effort as experienced in the past week. The seven items are reverse coded so that a higher score (range 0-14)
indicates increased sleep effort (e.g., "I feel I should be able to control my sleep at night").
Adequate reliability and validity of this measure has been established. 30 Beliefs and Attitudes about Sleep Scale (BAS). 32 The BAS is a 30-item measure of sleeprelated dysfunctional thinking. Individuals are asked to indicate the level of agreement on statements related to sleep; a strong endorsement of these statements is suggestive of dysfunctional beliefs and attitudes about sleep. The total scores were computed by summing all items, thus scores ranged from 0-300. The short-form version has acceptable internal consistency (Cronbach's alpha between 0.8 and 0.8) and adequate test-retest reliability across a 2-week interval (r= .8). 33 Pre-Sleep Arousal Scale (PSAS). 34 The PSAS is a 16-item questionnaire that assesses both cognitive and somatic arousal typically experienced during the sleep onset period. The total score ranges from 16-80 with a higher score reflective of increased arousal at bedtime.
Fatigue Severity Scale (FSS). 35 The FSS is a 9-item measure providing a global score of the intensity of an individual's fatigue and has good internal consistency (α = 0.8-0.9 34 ). Scores range from 9-63 with increased scores reflective of increased fatigue.
Epworth Sleepiness Scale (ESS). 27 The ESS is a brief 8-item questionnaire measuring the propensity for drowsiness or falling asleep in eight common situations and correlates Running head: Profile analysis of patients with insomnia 9 moderately with sleep latency at night and during daytime naps. 27 Total scores range from 0-24 with higher scores indicating increased subjective sleepiness.
Sleep diary. Prospective sleep diaries were completed daily across a 7-day period. The following variables were derived for analyses and were included in the analytic model (see used an in-house sleep diary that is similar to the consensus sleep diary, but did not separate WASO from early morning awakenings (EMA); study 2 used the consensus core sleep diary. 36 For study 2, EMA was added to WASO, so that this measure was comparable to study 1.
Polysomnography (PSG). Each participant completed a technician-monitored, in-laboratory
PSG to collect objective measures of sleep and respiratory events. Each study was scored by a registered polysomnography technologist and reviewed by a board-certified sleep medicine physician in accordance with the AASM Manual for the Scoring of Sleep and Associated Events. 37 For our analyses the following variables were extracted: total sleep time [PSG-measured total sleep time (TST)], and Apnoea-Hypopnea Index (AHI).
Statistical Analysis
Preliminary statistical analyses included descriptive statistics and assessment of normality of distributions. Data for continuous variables are presented as means and standard deviations and were compared between profiles using independent t-tests. Categorical variables are presented as percentages and were compared with the chi-squared test. The Statistical Package for the Social Sciences (SPSS) version 19.0 was used for all preliminary analyses.
Latent Profile analysis (LPA) was used to characterise insomnia symptom profiles.
LPA is an empirically driven approach, which uses continuous variables (or indicators) to derive latent clusters of individuals with a particular symptom profile. Symptom cluster membership is inferred by examining the patterns of interrelationships among individuals with the goal of maximizing homogeneity within class (or symptom cluster profile) and heterogeneity between classes. Therefore, underlying this method is an emphasis on differentiating individuals (individual-based approach) based on scores on various indicators, rather than on one particular variable (variable-based approach). The following continuous indicators were used to characterise insomnia symptom profiles: total scores on the 1) ISI, 2) GSES, 3) FSS, 4) BAS, 5) ESS, and 6) PSAS, as well as mean self-reported 7) SOL, 8) WASO, and 9) sleep efficiency from a 7-day sleep diary and 10) PSG-measured TST.
We used PSG-(rather than diary-) derived TST because of mounting evidence that insomnia with objective short sleep may form a distinct subtype of insomnia. 10, [38] [39] [40] [41] [42] The optimal number of symptom cluster profiles was determined after examination of the following fit indices: the Akaike information criteria (AIC), the Bayesian information criteria (BIC), the sample-size adjusted BIC (ABIC), log-likelihood (LL), entropy, the adjusted likelihood ratio test (ALRT), and the parametric bootstrapped likelihood ratio test (BLRT). 43 Important advantages of LPA over standard cluster techniques have been identified in the literature. 43 These include, for example, the ability to simultaneously include varying scales data in the same model, formal statistical criteria for selecting best fitting models, and most relevant to this study: the ability to examine associations between covariates and emerging profiles. Given this advantage, analyses were conducted in a two-step manner.
First, the continuous indicators listed above were included in the model to identify insomnia symptom cluster profiles. Second, covariates of symptom profiles were added to the model to examine cross-sectional associations between relevant covariates and symptom cluster profiles, using multinomial logistic regression. The following variables were entered as covariates: age, gender, education, race, ethnicity, BMI and AHI. Odds ratios (OR) of belonging to a symptom cluster with a specific symptom profile were estimated for each covariate. All tests were two-sided and α<0.05 was considered to be statistically significant. Mplus version 6.0 was used for all LPA analyses.
RESULTS
Descriptive Characteristics
Our sample was comprised of 175 individuals (n=110 female). Approximately 52.60% of individuals in our study identified as Caucasian, whereas 34.9%, 5.8%, 1.2% and 1.2% of the sample were African American, Asian, American Indian and Native Hawaiian, respectively. In regards to ethnicity, 8.8% of the sample identified as Hispanic/Latino. Mean age and education were 48.8 (SD=13.5) and 15.9 (SD=3.1) years, respectively. Mean AHI was significantly higher among men (M=21.0, SD=24.3) when compared to women (M=11.8, SD=19.2). No other significant differences in study variables were found across gender. In regards to AHI categories, 25.1% of the sample had mild OSA (AHI ≥5 and <15), 20.6% had moderate OSA (AHI ≥15 and <30) and 14.3% had severe OSA (AHI ≥30).
Detailed descriptive characteristics of the study sample are presented in Table 1 .
Characterisation of Insomnia Symptom Profiles
Multiple LPA models were examined with the number of symptom profiles (or latent clusters) ranging from 1 to 6. Fit indexes for all models are presented in Table 2 . The AIC, BIC, aBIC and LL values decreased as the number of classes increased, which suggests that a greater number of clusters fit the data progressively better. Similarly, the BLRT was significant across comparisons of progressively greater number of clusters. Entropy values for the 3-to 6-cluster solution ranged from 0.838 to 0.945, indicating good fit to the data across all clusters. The ALRT test, however, suggested that the three-cluster solution was the best fitting model as it was shown to perform significantly better than the 2-cluster solution (p=0.028). Further, the ALRT indicated that the 4-cluster solution was not significantly better than the three-cluster solution (p=0.161). In fact, proportion of individuals belonging to each cluster pronouncedly decreased as the number of clusters increased, and the 4-cluster solution included one symptom cluster profile comprised of only 8 individuals (5% of total sample). After collectively accounting for model fit indexes, as well as the size of each cluster, the 3-cluster solution was selected as best representing the data.
Based on visual examination of the severity and presentation of symptoms within the different profiles and discussion amongst the authors (MRC, DAC, JCO), the three latent symptom profiles were labeled the "High Subjective Wakefulness", "Mild Insomnia", and "Insomnia-related Distress". The "Mild Insomnia" symptom cluster profile was the largest comprising 79 (45.1%) individuals, followed by the "Insomnia-related Distress" and the "High Subjective Wakefulness" symptom cluster profile with 50 (28.6%) and 46 (26.3%) individuals, respectively.
Means and standard deviation of all indicators (self-report scales, 7-day sleep diary variables, and PSG TST) across each symptom cluster profile are presented in Table 3 . As shown in Figure 1 
Symptom Cluster Membership Covariates
The inclusion of covariates to the model (age, gender, education, race, ethnicity, AHI category and BMI category) did not significantly alter the indicator mean scores for each symptom cluster profile, which further confirms the stability of the 3-cluster solution.
Unadjusted mean values and percentages for each predictor by the three insomnia symptom cluster profiles are presented in Table 3 .
Participants across all insomnia symptom cluster profiles were comparable in terms of gender, education, race and ethnicity. However, significant predictors of symptom cluster membership included age, OSA severity, and BMI category (see Table 4 for unstandardized odds ratios for all variables). In terms of age, older participants were significantly more likely to belong to the "High Subjective Wakefulness" profile than the "Insomnia-related Distress" profile (OR=1.052, p=0.025) or the "Mild Insomnia" profile (OR=1.046, p=0.019). This indicates that for every one year increase in age participants were 5% more likely to belong to the "High Subjective Wakefulness" profile when compared to the "Insomnia-related Distress" or "Mild Insomnia" profile. No significant differences in age were found between the "Mild Insomnia" and "Insomnia-related Distress" profiles. In regards to AHI, participants with higher degree of OSA severity were significantly more likely to belong to the "Mild Insomnia" profile when compared to the "Insomnia-related Distress" (OR=1.870, p=0.018) or the "High Subjective Wakefulness" (OR=1.639, p=0.047) profiles. In fact, for every progressive increase in OSA severity category (no OSA vs. mild vs. moderate vs. severe), there was an 87% increase in the odds of belonging to the "Mild Insomnia" as compared to the "Insomnia-related Distress"profile.
Similarly, for every progressive increase in OSA severity category, there was a 64% increase in participant's odds of belonging to the "Mild Insomnia" profile as compared to the "High Subjective Wakefulness" profile. Finally, when adjusting for OSA severity, participants with greater degree of obesity were more likely to belong to the "Insomniarelated Distress" than the "Mild Insomnia" (OR=1.804, p=0.008) profile. This indicates that overweight/obese participants had an 80% increase in their odds to belong to the "Insomnia-related Distress" profile when compared to the "Mild Insomnia" profile. No significant differences in BMI category were found between the "High Subjective
Wakefulness" profiles and the other two symptom cluster profiles.
DISCUSSION
Considering the heterogeneity of insomnia disorder, a symptom-based approach is a timely consideration. The aim of our study was to generate symptom cluster profiles, which could guide development of models of patient-centered care. A symptom cluster-based approach might provide a more personalised, precise management of the patient's primary complaints. Unique patterns nested within the symptom cluster would otherwise be lost. 59 To do this, we used a different data-driven approach (latent profile analysis, LPA) in a sample of individuals who represent patients presenting to a sleep clinic for insomnia symptoms.
Compared to most previous studies, we used data-driven methods here to characterise the heterogeneity, rather pre-determined categories as used in other studies.
For example, pre-determined categories have included insomnia disorder subtypes, such as psychophysiological, paradoxical, idiopathic insomnia, insomnia related to a mental disorder, wich have been associated with different disease characteristics, 44-46 treatment perceptions 46, 47 and treatment responses. 46, 48 Nightly insomnia symptoms (sleep onset or sleep maintenance problems or early morning awakenings) have also been associated with different disease characteristics [49] [50] [51] [52] [53] [54] [55] and treatment responses. 56, 57 More recently, the heterogeneity driven by objective total sleep time has garnered attention. A number of studies have highlighted differential outcomes associated with short vs. long objective sleep. [38] [39] [40] [41] [42] 58 In contrast to these top-down approaches, data-driven methods, such as cluster analysis, have been applied to this area and have revealed that daytime symptoms such as sleepiness, fatigue, mood and sleep hygiene practices, 9 nighttime symptoms such as objective sleep parameters, 10 night-to-night variability and longitudinal development of subjective sleep variables 11, 16 and dysfunctional beliefs about sleep 12 uniquely fall together in identifiable and meaningful clusters. Others have used both sleep and psychiatric history, and daytime and nighttime symptoms to identify symptom clusters. 8 To our knowledge, only two studies to date have used sophisticated mixture models to derive symptom cluster profiles in individuals with sleep disturbances 17 or from a population-based sample. 16 Foley and colleagues identified four symptom clusters ("weekly sleep disturbance and distressed", "transient sleep disturbances", "early morning awakenings" and "comorbid & non-restorative sleep"). Also using latent class analysis, Green and colleagues derived four symptom profiles, "healthy with low reports of sleep problems", "episodic reports of sleep problems", "developing over the 20 years" and "chronic problems of both sleep onset and maintenance problems". 16 Our latent profile analysis reported here, builds on these previous studies. The symptom cluster profiles that emerged in our study were characterised by the following symptoms: increased selfreported wakefulness ("High Subjective Wakefulness"), low reporting of insomnia symptoms ("Mild Insomnia") and high distress about sleeplessness and its consequences, ("Insomnia-related Distress").
"High Subjective Wakefulness" symptom cluster profile
The "High Subjective Wakefulness" symptom cluster profile was best characterised by the 17 : the "difficulty maintaining sleep" group also reported high rates of sleep maintenance problems. Interestingly, PSG-derived total sleep time of the HSW symptom cluster profile did not vary greatly from the other two profiles (10-20 minute difference), yet the HSW reported taking 30 minutes longer to fall asleep than those with the mild insomnia profile and 90 minutes more wakefulness in the middle of the night than the other two symptom cluster profiles, which suggest potential overestimation of subjective wakefulness in the HSW symptom cluster profile. It is noteworthy, however, that this study used one night of PSG to determine objective total sleep time, compared to an average 7day sleep diary, hence measurement bias reduces the ability to estimate true extent of the sleep misperception. In addition, the use of only one PSG night raises the potential influence of "first-night effects". Future replications, ideally with multiple consecutive nights, are needed at this stage; however it is worth mentioning that recent evidence emerged indicating the validity of one PSG night in the classification of short vs. long objective total sleep time for individuals with insomnia. 60 The statistical method of latent profile analysis enabled us to examine predictors of symptom cluster membership. Because participants of older age were more likely to belong to the HSW symptom cluster profile than to the other two symptom cluster profiles, it is possible that the observed elevation in subjective wakefulness might be explained in part by age-related increase in WASO. 61 The average objective total sleep time for this symptom cluster profile -just above 6 hrs.-was below the sample's overall average, thus individuals with this symptom profile might benefit from therapeutic approaches that lead to rapid sleep consolidation, for example sleep restriction, stimulus control or sedativehypnotics. Whether some of these individuals present with similar characteristics and sequelae as the symptom cluster profile "insomnia with objective short sleep" 10, [38] [39] [40] 42, 58 remains to be elucidated in future studies. The results in the current study indicated that this symptom profile had the highest percent of cases with OSA overall and per severity level among the three symptom profiles.
"Mild Insomnia" symptom cluster profile
This symptom cluster profile might represent individuals with comorbid OSA and insomnia, who may not identify insomnia as their chief complaint. In a previous study on OSA and comorbid insomnia, we found that a quarter of the sample (24.1%) identified OSA (rather than insomnia) as their primary complaint. 7 This finding has important clinical implication and could improve the precision and cost-effectiveness of evaluations conducted at sleep disorders clinics. Specifically, whereas PSG is not currently recommended for the routine assessment of insomnia, 62 a patient presenting for the treatment of insomnia whose symptom profile fits the "Mild Insomnia" symptom cluster profile might benefit from a PSG to evaluate the possible presence of OSA. The danger of OSA going undetected among insomnia patients has been previously documented. Krakow and colleagues found that in patients endorsing insomnia but no sleep disordered breathing (SDB) symptoms, most nighttime awakenings actually followed respiratory events, unbeknownst to the patient, 63 and 50% of the sample met criteria for OSA. Fung et al. found that nearly half of study participants with insomnia suffered from occult SDB (AHI ≥ 15), and the presence of excessive daytime sleepiness was the distinguishing factor between occult and non-existent SDB. 64 In the primary care setting, insomnia was found to predict OSA irrespective of age. 65 Cronlein and colleagues found that occult OSA was most likely to be found on PSG in older and overweight individuals with insomnia, alluding to the possible necessity for PSGs in these patients. 66 men with insomnia who frequently reported dry mouths were likely to have occult sleep apnoea even after been screened for possible OSA. 67 Our findings complement these studies by highlighting the risks of occult OSA in insomnia patients, and this might be particularly prominent in those with the "Mild Insomnia" symptom profile. For this profile, treatment of insomnia using brief behavioural therapy 68-70 might suffice, and these patients might require concomitant treatment for both insomnia disorder and OSA.
We did not include participants who were excluded prior to the PSG screening evaluation (e.g., those who had a high [study 1] or low risk [study 2] for OSA based on subjective symptoms such as snoring or witness apnoeas or based on medical examination). This selection method might have biased our results, as we are left with two distinct samples at two extremes of the continuum: insomnia + no OSA for study 1, and insomnia + OSA for study 2. This selection bias might lead to an overrepresentation of the mild insomnia profile. In contrast, our analysis did include participants who underwent a screening PSG, even if they were excluded post-PSG from each individual parent study, which increases the selection of insomnia patients with comorbidities to a greater extent that most previous studies have done.
"Insomnia-related Distress" symptom cluster profile
Finally, the "Insomnia-related Distress" symptom cluster profile was characterised by the highest reports of sleep-interfering mental activity and of fatigue. This profile is very similar to previously reported clusters> Sánchez-Ortuño and colleagues' "worried and symptom focused" and "worried and medication biased" clusters; Edinger and colleagues' "bedtime arousal" cluster; and Foley et al's "distressed" cluster. 8 These clusters are all characterised by pre-sleep arousal, distress, worry or dysfunctional beliefs about sleep.
Interestingly, in the current study, those belonging to the "Insomnia-related Distress" symptom cluster profile were more likely to have no or mild OSA. Thus PSG evaluation would not likely be indicated, unless other risk factors such as snoring or witness apnoeas have been reported. Particularly noteworthy are the high rates of fatigue in this cluster, despite relatively comparable levels of daytime sleepiness to the other profiles (see table 3 and figure 1, 2); this dichotomy is not present in other symptom cluster profile. The dissociation between fatigue and sleepiness ratings has been highlighted previously, with the former more frequently reported in insomnia. 73, 74 Controlling for OSA severity, overweight/obese participants were more likely to belong to the "Insomnia-related Distress" than the "Mild Insomnia" symptom cluster profile. Our findings report on cross-sectional data, thus preclude inference about causal relationships between insomnia-related distress and obesity; however these results might suggest avenues for further investigation. Others have reported an association between obesity, insomnia and emotional stress, 71 and psychological stress has been associated with changes in the production of appetite regulating hormones, such as ghrelin. 72 Patients who present with a symptom profile consistent with the "Insomnia-related Distress" symptom cluster profile might benefit from a treatment plan that includes cognitive therapy, mindfulness or relaxation strategies to reduce the arousal, and distress and a mix of cognitive and behavioural components to address fatigue.
One notable limitation that is relevant to this symptom profile is that parent study 1 specifically recruited individuals with psychophysiological insomnia, thus individuals with heightened somatic and cognitive arousal at bedtime were overrepresented in this sample.
This sample selection might have contributed to an overrepresentation of this symptom profile.
Implications for clinical practice
With our analysis we supplement previous data-driven attempts to characterise the symptoms cluster profiles within insomnia disorder. Symptom cluster profiles add important clinical data that may be lost when individuals are grouped within one single diagnostic boundary. These symptom cluster profiles might also transcend diagnostic boundaries: in clinical practice, insomnia patients often share symptoms with other medical, psychiatric or sleep disorders, and so treatment decisions that are guided by symptom clusters, will not be biased by symptom overlap across comorbidities. We hope that these results, along with other attempts, will inform clinical practice by guiding patient-centered care. We can see the success of these approaches in other areas such as oncology, 75 asthma, 76 and various psychiatric disorders. 77 The heterogeneity within insomnia disorder, lends itself to such an approach.
We currently define insomnia disorder as a distinct entity, and our management of insomnia disorder is a one-size-fits-all approach, simply because we do not have sufficient evidence for a) valid and meaningful symptom cluster profiles, and b) whether treatments can be tailored to these symptom cluster profiles. The attempts to date, including ours and future studies will help to move the needle towards a more patient-centred approach, which is gaining popularity in the US. With established and validated symptom clusters, we envision the practitioner can make assessment and treatment decisions based on the symptom cluster each individual patient reports. These findings are hopefully a catalyst for a dimensional profile of sleep health 19 which might be useful for reducing the gap between patient experiences, and clinical decision making based on categories. A symptom profile based approach represents the middle ground on the dimension from very individualised medicine on the one side, and a one-size-fits-all approach on the other side. This approach would be more effective than the one-size-fits-all approach, because symptoms specific to the individual's symptom profile are targeted, but more feasible in our current health system (particularly in the US) than an entirely individualised one, where time and cost limitations play a considerable role. We envision that established and validated symptom profiles will offer the practitioner with a model for patient-centered management of insomnia disorder.
Summary
Our results revealed three different symptom clusters in a group of individuals presenting with insomnia complaints, highlighting the symptom heterogeneity within insomnia disorder. Hopefully, these results provide an impetus for a symptom-based approach to the management of insomnia disorder. We intentionally selected self-reported variables for the profile analysis that have been recommended for the clinical evaluation of insomnia 86 so that these results can easily translate to clinical practice. The vision is that the patient's profile from these clinical measures could guide clinical decision-making when treating insomnia. Undoubtedly though, before this approach can be translated into a model for interdisciplinary sleep clinics, further research is needed. 
